2020, January 29-February 1: How Senior Citizens from Cold Climates Deal with GI Biopsies in the Desert
Jan. 29 - Feb. 1, 2020 - Palm Springs, California
24 CME / 24 SAMs
Gastrointestinal pathology emerged as a subspecialty in the early 1980s, roughly coincident with development of endoscopy and mucosal biopsy for diagnosis and management of patients with gastrointestinal disorders. At that time, a number of pathologists dedicated their efforts to recognizing and classifying patterns of disease based on careful morphologic assessment, unassisted by immunohistochemical and molecular techniques. Many of their observations and conclusions have held true for several decades underscoring their validity. These individuals have tremendous knowledge to share with learners at all stages in their careers, many of whom have come to rely heavily on ancillary tests to establish diagnoses rather than morphologic assessment. Pathologists must be able to hone-in on key features in order to narrow the differential diagnosis and facilitate patient management. This special Emeritus course concentrates on the pioneers in gastrointestinal pathology and their prophetic perspectives.
- Recognize and classify dysplasia in the setting of Barrett esophagus
- Distinguish diagnostic features of medication and pathogen-related intestinal injury in the immunocompromised host
- Formulate a differential diagnosis for sprue-like lesions of the small bowel
- Distinguish invasive adenocarcinoma from mimics in biopsy material
- Henry D. Appelman, MD
University of Michigan
- Linda D. Ferrell, MD
University of California San Francisco (UCSF)
- Audrey J. Lazenby, MD
University of Nebraska School of Medicine
- Frank A. Mitros, MD
University of Iowa, Carver College of Medicine (Professor, Emeritus)
- David A. Owen, MB, BCh, FRCPC
University of British Columbia
- Robert Riddell, MD, FRCPath, FRCPC
University of Toronto
- Dale C. Snover, MD
University of Minnesota
USCAP appreciates the contribution of Dr. Rhonda Yantiss for facilitating this special course.
CONTINUING MEDICAL EDUCATION AND CONTINUING CERTIFICATION
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of 24 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USCAP is approved by the American Board of Pathology (ABPath) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABPath requirements for Continuing Certification (CC). Physicians can earn a maximum of 24 SAM credit hours.
USCAP records courses at the Interactive Learning Center for future educational purposes. By registering for this course, you consent that your likeness may be used by USCAP.
Cancellations will be assessed an administrative charge of 25% of the total registration fee. There will be no refunds for cancellations within 14 days of the event. The Academy is not responsible for travel expenses incurred as a result of an event cancellation.